7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

#f

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/9/26 17:00
9/4/26
IDXXIdexx Laboratories Inc /DeDEHealthDiagnIn Vitro & In Vivo DiagnosticKingsley Lawrence DMED1S.d-1,172532.080-210D
9/8/26 16:51
9/3/26
CATXPerspective Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLantheus Alpha Therapy, LLCMAT2S.m-9083.130-29011,521D
9/3/26 16:54
9/1/26
CATXPerspective Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLantheus Holdings, Inc.MAT2S-3573.140-11411,599D
8/24/26 16:05
8/20/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLeonard John MMADOP,CEO1S.m-28712.650-231,205D
8/21/26 16:30
8/19/26
ACHVAchieve Life Sciences, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticStewart Richard AlistairWAD1S-1758.490-21209D
7/24/26 17:26
7/2/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticDulac Edward J IIIMAOEVP,CFO2S-17513.720-13156D
7/6/26 17:02
7/1/26
NTLAIntellia Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticDube Michael PMAOVP,Chief1S-4416.780-367D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact